Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 4Neoplasms 4Colorectal Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1Sepsis 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Intestinal Neoplasms 1Inflammation 1Infections 1Hematologic Neoplasms 1Glioblastoma 1Fever 1Febrile Neutropenia 1Exanthema 1Emergencies 1Duodenal Neoplasms 1Discitis 1

Interventions

Gels 2Fulvestrant 2Doxycycline 2Dapsone 2ruxolitinib 1dexpanthenol 1ceterizine hydrochloride 1capivasertib 1benralizumab 1Triamcinolone Acetonide 1Tetracycline 1Sirolimus 1Provitamins 1Prednisone 1Panitumumab 1Minocycline 1Loperamide 1Irinotecan 1IFL protocol 1Hydrocortisone 1Erlotinib Hydrochloride 1Clindamycin 1Cetuximab 1Anti-Bacterial Agents 1Alpelisib 1Acitretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Exanthema × Anti-Bacterial Agents × Clear all
NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
11 enrolled 7 charts
Gastrointestinal

Exanthema, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡